Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aveir VR Coverage With Evidence Development Post-Approval Study

NCT: NCT05336877 · ACTIVE_NOT_RECRUITING

NCT IDNCT05336877
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-21
Completion2028-01-01
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑